Literature DB >> 1505314

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers.

C A Hofmann1, J R Colca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1505314     DOI： 10.2337/diacare.15.8.1075

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  22 in total

Review 1.  Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments.

Authors:  A J Scheen
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

2.  Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.

Authors:  C B Kallen; M A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Insulin action on protein phosphatase-1 activation is enhanced by the antidiabetic agent pioglitazone in cultured diabetic hepatocytes.

Authors:  S Pugazhenthi; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 4.  Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism.

Authors:  R Donnelly; A D Morris
Journal:  Br J Clin Pharmacol       Date:  1994-04       Impact factor: 4.335

5.  MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone.

Authors:  Mark L Paddock; Sandra E Wiley; Herbert L Axelrod; Aina E Cohen; Melinda Roy; Edward C Abresch; Dominique Capraro; Anne N Murphy; Rachel Nechushtai; Jack E Dixon; Patricia A Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

6.  Reversing the curse on PPARγ.

Authors:  Mitchell A Lazar
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

7.  Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect.

Authors:  T A Buchanan; W P Meehan; Y Y Jeng; D Yang; T M Chan; J L Nadler; S Scott; R K Rude; W A Hsueh
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Insulin sensitizing pharmacology of thiazolidinediones correlates with mitochondrial gene expression rather than activation of PPAR gamma.

Authors:  Charles W Bolten; Patrick M Blanner; William G McDonald; Nicholas R Staten; Richard A Mazzarella; Graciela B Arhancet; Martin F Meier; David J Weiss; Patrick M Sullivan; Alexander E Hromockyj; Rolf F Kletzien; Jerry R Colca
Journal:  Gene Regul Syst Bio       Date:  2007-09-17

9.  Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene.

Authors:  V Ribon; J H Johnson; H S Camp; A R Saltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 10.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.